Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Wyeth has licensed Inovio Biomedical's DNA delivery technology for vaccines for an up-front fee of $4.5 million. Wyeth will also pay undisclosed license maintenance fees, research support payments, and up to $60 million in milestone payments. Inovio says its MedPulser electroporation technology has been shown in primate studies to sharply boost the immune response to DNA vaccines compared with the response to DNA plasmid delivered via standard injection.
This article has been sent to the following recipient: